Altogether, these results strongly support that the downregulation of Trk signaling is instrumental in inhibiting the invasiveness of cSCC cells in vivo and disrupts the metastatic cascade in cSCC by modulating key pro-invasive pathways, including FAK and EMT markers. This evidence concerns the gene PTK2 and skin squamous cell carcinoma.